Clinical trial
Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in…
NCT00362947 · IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other · Completed
Key facts
| NCT number | NCT00362947 |
|---|---|
| Title | Different Doses and Duration of Low Molecular Weight Heparin (Parnaparin)in Superficial Vein Thrombosis |
| Official title | Randomized Clinical Study of Different Treatment Doses and Duration of Low Molecular Weight Heparin (Parnaparin) in Superficial Vein Thrombosis |
| Lead sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thrombophlebitis |
| Intervention type | Drug |
| Interventions | LMWH parnaparin subcutaneously |
| Enrollment | 664 |
| Start date | Aug 1, 2006 |
| Primary completion | Sep 1, 2010 |
| Completion | Feb 1, 2011 |
| First posted | Aug 15, 2006 |
| Last update posted | Mar 19, 2021 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: